Anxiety and Depression Among Patients with Diabetes in Saudi Arabia and Egypt

Here are the Anxiety and Depression Among Patients with Diabetes in Saudi Arabia and Egypt journals presenting the latest research across various disciplines. From social sciences to technology, each article is expected to provide valuable insights to our readers.

Difference between anxiety and depression, anxiety and depression among patients with creutzfeldt jacob, prayers for anxiety and worry, anxiety and depression among patientsite, anxiety and depression medication, anxiety and depression association of america, buspar for anxiety and depression.

Anxiety and Depression Among Patients with Diabetes in Saudi Arabia and Egypt

Background: Mental stress plagued type II diabetes (T2DM) patients. The psychological and emotional issues related to diabetes and its effects include depression, anxiety, poor diet, and hypoglycemia fear. Aim: Compare the impact of diabetes on depression and anxiety in Egyptian and Saudi diabetics.

Methods: The diabetes, gastroenterology, and hepatology sections of University of Ha'il Clinic, KSA, and the Theodor Bilharz Research Institute, Egypt, conducted this retrospective study. Everyone gave informed consent before participating. Interviews with male and female outpatients and inpatients were conducted from June 2021 to December 2022. The self-administered validated Generalized Anxiety Disorder-7 (GAD-7) and the Patient Health Questionnaire-9 (PHQ-9) scale measured sociodemographic characteristics and symptoms of depression and anxiety.

Results: In patients with diabetes, the prevalence of depress ion was higher in KSA [34.8%] than in Egypt [18%], while anxiety was higher in Egypt [40%] than in KSA [29.1%]. Most depressed patients were 31–55 years old (61.2%) from KSA and 97.8% (41–55 years old) from Egypt. Female anxiety was 70.7% in KSA and 51.0% in Egypt, with no significant difference. The duration of diabetes in depressed patients was 5–10 years ([46.9%, Saudis] vs. [57.8%, Egyptians]), while anxious patients (5–10 years [39.0%, Saudis] vs. >20 years [65.0%, Egyptians]) were mainly type-2. Most depressive patients had an HbA1c (59.2%) from 7–10% (Saudis) and 77.8% [>10% Egyptians] compared to anxiety patients (46.3%) and 48.0% [>10% Egyptians]. Depressed and anxious patients from both nations had higher glucose, triglycerides, and cholesterol levels. Saudis and Egyptians with obesity had higher rates of sadness (75.5% vs. 68.9%) and anxiety (82.9% vs. 69.0%). Treatment adherence and serum glucose monitoring were not significantly different from depression in di abetes individuals in both ethnicities. Conclusions: Anxiety was more common among Egyptian patients because of overcrowding, working whole days to fulfill life requirements, and the unavailability of health insurance to all citizens. Meanwhile, in KSA, obesity, unhealthy food, and less exercise reflect the high percentage of depression among patients with diabetes. The detection of depression and anxiety in the context of DM should be critical for the physical health and quality of life of Saudi and Egyptian diabetics. Further investigation is warranted to encompass anxiety and depression within the scope of future research. © 2024 by the authors.

Authors : Mahmoud M.R.; Aljadani A.; Razzak Mahmood A.A.; Alshammari R.F.; Shahien M.M.; Ibrahim S.; Abdel Khalik A.; Alenazi F.S.; Alreshidi F.; Nasr F.M.; Alreshidi H.F.; Alshammari A.D.; Abdallah M.H.; El-Horany H.E.-S.; Said K.B.; Saleh A.M.

Source : Multidisciplinary Digital Publishing Institute (MDPI)